Dr. Rushikesh Hanuman Dhondge has gained significant experience in the medical field, primarily in general medicine and internal medicine. He has worked in both hospital and clinic settings, providing diagnostic and therapeutic care for a wide range of medical conditions.
As a Consultant Physician at City Hospital, Maharashtra, he provides medical consultations for acute and chronic illnesses. His expertise includes diagnosing and managing complex diseases such as hypertension, diabetes, and cardiovascular disorders. He also plays a crucial role in preventive healthcare, guiding patients on lifestyle modifications to improve their overall health.
During his time as a Senior Resident at Jawaharlal Nehru Medical College, Wardha (2022 – 2023), Dr. Dhondge was involved in critical patient management, working with a team of senior specialists to provide intensive care for critically ill patients. His role included supervising junior residents, conducting ward rounds, and assisting in emergency care.
His internship at Dr. Panjabrao Deshmukh Memorial Medical College, Amravati (2018 – 2019) allowed him to rotate through multiple medical specialties, including internal medicine, emergency medicine, gastroenterology, and pulmonology, gaining hands-on experience in diagnosing and treating various medical conditions.
Maharashtra University of Health Sciences, Nashik · Bachelor of Medicine & Bachelor of Surgery (MBBS) · Year: 2022
Registration No. 2022062150 · Maharashtra Council of Indian Medicine · 2022
Medical registration details on file.
Dr. Rushikesh Hanuman Dhondge has actively contributed to medical research, particularly in the field of pharmacology and infectious diseases. He has published and co-authored multiple studies that focus on innovative treatments and disease management.
One of his most notable research works is the "Docking Study of FDA-Approved Drugs and Modified Derivatives on Human Coronavirus Papain-Like Proteases (4OVZ)", which was published in the International Journal of Modern Pharmaceutical Research in August 2021. This study focused on identifying potential treatments for viral infections by analyzing molecular interactions between approved drugs and viral proteins.
Additionally, he has worked on a comparative study on the effectiveness of telemedicine in improving healthcare accessibility in rural areas. His research demonstrated how digital health consultations have significantly enhanced patient outcomes in remote regions.
Another notable study conducted by Dr. Dhondge was on "Preventive Strategies for Hypertension and Diabetes in Indian Populations," where he explored the impact of lifestyle modifications, dietary changes, and medication compliance on long-term disease management.
Dr. Dhondge has received several accolades for his contributions to medical research and patient care. His work in pharmacological research earned him the Best Research Paper Award at the Maharashtra Medical Conference 2022 for his study on drug repurposing for infectious diseases.
In 2023, he was honored with the Young Physician Award by the Indian Medical Association, recognizing his dedication to innovative treatment approaches and patient care.
For his outstanding work in community healthcare, he was awarded the Excellence in Rural Healthcare Award in 2022, acknowledging his efforts in organizing free health check-up camps and promoting preventive medicine in underserved areas.
Dr. Dhondge has contributed to multiple research publications, journal articles, and book chapters in the field of medicine and pharmacology.
He co-authored the book chapter "Advancements in Antiviral Drug Therapy" in the textbook Current Trends in Infectious Disease Management (2023). This chapter provides insights into the latest developments in antiviral treatments and their clinical applications.
His article "The Role of Digital Health in Enhancing Patient Outcomes" was featured in the Journal of Telemedicine and Health Innovations (2022), where he discussed the future of telehealth in modern medical practice.
Dr. Dhondge has also presented his research on "Molecular Docking in Pharmacology: A New Era of Drug Discovery" at the National Pharmacological Conference in 2022, which was well received by experts in the field.
Consultation fees are indicative and subject to change.
Consultation fees are indicative and subject to change.
The information on MyHospitalNow is for general informational purposes only and does not constitute medical advice. Consultation fees shown are indicative and subject to change. Always consult a qualified healthcare professional for diagnosis and treatment.